{"id":"W2071925985","doi":"10.6000/1927-7229.2015.04.01.4","title":"Adverse Effects of Bevacizumab During Treatment for Metastatic Colorectal Cancer","year":2015,"lang":"en","type":"article","venue":"Journal of Analytical Oncology","topic":"Colorectal Cancer Treatments and Studies","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"","keywords":"Bevacizumab; Medicine; Oxaliplatin; Colorectal cancer; Internal medicine; Adverse effect; Clinical endpoint; Chemotherapy; Incidence (geometry); Oncology; Cancer; Surgery; Gastroenterology; Randomized controlled trial","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":true,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001531683,0.0001391991,0.0009762947,0.0001444176,0.00003202065,0.000002305927,0.00004796106,0.00005784477,0.00003307583],"category_scores_gemma":[0.000373236,0.00008632356,0.0003524383,0.0001289213,0.0001098235,0.00004696551,0.00002031626,0.00009184924,0.000001766226],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001436033,"about_ca_system_score_gemma":0.0008092783,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00005033664,"about_ca_topic_score_gemma":0.00009155157,"domain_scores_codex":[0.9989197,0.00004744083,0.0004906316,0.0001145126,0.0002193472,0.0002083248],"domain_scores_gemma":[0.9985142,0.0003754109,0.0003230671,0.00006591406,0.0004610934,0.0002602579],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.2868576,0.03486241,0.2134333,0.004034488,0.07193835,0.01804869,0.01947391,0.001639849,0.04022459,0.002539081,0.01589457,0.2910531],"study_design_scores_gemma":[0.1939956,0.3354671,0.262297,0.0009626919,0.03494509,0.003613757,0.004170205,0.002822508,0.08574642,0.001394957,0.07382459,0.0007600215],"study_design_candidate":"randomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9949109,0.001861106,0.00006092461,0.001349694,0.0003771582,0.0003983123,0.00000980253,0.000004813983,0.001027293],"genre_scores_gemma":[0.9974205,0.0003979056,0.001378291,0.0000616742,0.0002253441,0.00003835452,0.000001325009,0.00001142387,0.0004651035],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.3006047,"threshold_uncertainty_score":0.3755175,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.05110533507997374,"score_gpt":0.3925015939768131,"score_spread":0.3413962588968394,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}